Targeting Neutrophilic Inflammation Using Polymersome-Mediated Cellular Delivery

Area of Science:

• Immunology and Cell Biology
• Nanotechnology and Drug Delivery
• Biomedical Engineering

Background:

• Neutrophils are crucial immune cells involved in pathogen defense and inflammation.
• Delayed neutrophil apoptosis contributes to tissue damage and chronic inflammatory diseases.
• Targeting neutrophils for therapeutic intervention is challenging due to difficulties in experimental manipulation.

Purpose of the Study:

• To develop a novel drug delivery system for neutrophils.
• To investigate the efficacy of polymersomes for intracellular delivery of therapeutic compounds into neutrophils.
• To promote neutrophil apoptosis and accelerate inflammation resolution.

Main Methods:

• Utilized biocompatible, nanometer-sized polymersomes for drug encapsulation and delivery.
• Engineered polymersomes for scavenger receptor-mediated uptake and pH-triggered endosomal escape.
• Delivered (R)-roscovitine, a cyclin-dependent kinase inhibitor, into human neutrophils in vitro.
• Assessed inflammation resolution in a transgenic zebrafish model using encapsulated (R)-roscovitine.

Main Results:

• Polymersomes successfully delivered therapeutic molecules into the neutrophil cytosol without causing cellular activation.
• Optimized polymersome size enabled efficient delivery of (R)-roscovitine to promote neutrophil apoptosis in vitro.
• Encapsulated (R)-roscovitine accelerated inflammation resolution in vivo more effectively than the free drug.

Conclusions:

• Polymersomes serve as effective intracellular carriers for targeted drug delivery into neutrophils.
• This technology holds significant potential for advancing neutrophil biology research.
• The findings pave the way for developing novel neutrophil-targeted therapeutics for inflammatory conditions.